Liver Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must be willing and able to sign a consent form to take part in the study.
• You must be 18 years old or older.
• You must have been diagnosed with advanced or inoperable liver cancer (hepatocellular carcinoma, or HCC), confirmed by tissue sample or imaging scans.
• Your liver cancer must be at a specific stage known as BCLC B or C (confirm with trial site if unsure of your stage).
• Your liver must be functioning at a level called Child-Pugh A, with a score of 5 or 6 (confirm with trial site).
• You must be generally well enough to carry out light daily activities, rated 0 or 1 on a standard health scale used in cancer care (confirm with trial site).
• You must not have received any treatment for your advanced liver cancer yet, and your doctor must be planning to treat you with a specific combination therapy called STRIDE as your first treatment.

Who may not be able to join:

• You have previously received any drug-based (systemic) treatment for your liver cancer.
• You have had or are currently receiving any type of immunotherapy treatment.
• You have previously had an organ transplant or bone marrow transplant from another person.
• You have had active or documented bleeding in your stomach or gut at any point in the last 12 months.
• You have a blood clot blocking the main blood vessel leading to your liver (main trunk portal vein thrombosis).
• You have an autoimmune disease (where your immune system attacks your own body) that requires medication to suppress your immune system.
• You have a known allergy or sensitivity to any of the ingredients in the STRIDE treatment.
• You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.